Literature DB >> 3903753

Nasal absorption of insulin: enhancement by hydrophobic bile salts.

G S Gordon, A C Moses, R D Silver, J S Flier, M C Carey.   

Abstract

We demonstrate that therapeutically useful amounts of insulin are absorbed by the nasal mucosa of human beings when administered as a nasal spray with the common bile salts. By employing a series of bile salts with subtle differences in the number, position, and orientation of their nuclear hydroxyl functions and alterations in side chain conjugation, we show that adjuvant potency for nasal insulin absorption correlates positively with increasing hydrophobicity of the bile salts' steroid nucleus. As inferred from studies employing various concentrations of unconjugated deoxycholate and a constant dose of insulin, insulin absorption begins at the aqueous critical micellar concentration of the bile salt and becomes maximal when micelle formation is well established. These and other data are consistent with the complementary hypotheses that bile salts act as absorption adjuvants by producing high juxtamembrane concentrations of insulin monomers via solubilization in mixed bile salt micelles and forming reverse micelles within nasal membranes, through which insulin monomers can diffuse through polar channels from the nares into the blood stream.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3903753      PMCID: PMC391356          DOI: 10.1073/pnas.82.21.7419

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  Crystallization of sodium taurocholate.

Authors:  J L Pope
Journal:  J Lipid Res       Date:  1967-03       Impact factor: 5.922

2.  Effect of bile salts on the rectal absorption of sodium ampicillin in rats.

Authors:  T Murakami; Y Sasaki; R Yamajo; N Yata
Journal:  Chem Pharm Bull (Tokyo)       Date:  1984-05       Impact factor: 1.645

3.  Examination of insulin formulations using quasi-elastic light scattering.

Authors:  H Martindale; J Marsh; F R Hallett; A M Albisser
Journal:  Diabetes       Date:  1982-04       Impact factor: 9.461

4.  A cubic protein-monoolein-water phase.

Authors:  B Ericsson; K Larsson; K Fontell
Journal:  Biochim Biophys Acta       Date:  1983-03-23

5.  Passage of molecules through the wall of the gastrointestinal tract. Intestinal permeability to polyethylene glycols in the 414- to 1,074-dalton range.

Authors:  C Tagesson; R Sjödahl
Journal:  Eur Surg Res       Date:  1984       Impact factor: 1.745

6.  Effects of insulin on the lipid structure of liver plasma membrane measured with fluorescence and ESR spectroscopic methods.

Authors:  P A Hyslop; D A York; R D Sauerheber
Journal:  Biochim Biophys Acta       Date:  1984-10-03

7.  The influence of bile salt structure on self-association in aqueous solutions.

Authors:  A Roda; A F Hofmann; K J Mysels
Journal:  J Biol Chem       Date:  1983-05-25       Impact factor: 5.157

8.  Intranasal administration of human pancreatic tumor GH-releasing factor-40 stimulates GH release in normal men.

Authors:  W S Evans; J L Borges; D L Kaiser; M L Vance; R P Sellers; R M MacLeod; W Vale; J Rivier; M O Thorner
Journal:  J Clin Endocrinol Metab       Date:  1983-11       Impact factor: 5.958

9.  Bile salts as atypical surfactants and solubilizers.

Authors:  P Mukerjee; Y Moroi; M Murata; A Y Yang
Journal:  Hepatology       Date:  1984 Sep-Oct       Impact factor: 17.425

10.  Insulin administered intranasally as an insulin-bile salt aerosol. Effectiveness and reproducibility in normal and diabetic subjects.

Authors:  A C Moses; G S Gordon; M C Carey; J S Flier
Journal:  Diabetes       Date:  1983-11       Impact factor: 9.461

View more
  55 in total

1.  The molecular weight dependence of nasal absorption: the effect of absorption enhancers.

Authors:  M D Donovan; G L Flynn; G L Amidon
Journal:  Pharm Res       Date:  1990-08       Impact factor: 4.200

2.  Influence of absorption promoters on pulmonary insulin bioactivity.

Authors:  T Mahesh Kumar; Ambikanandan Misra
Journal:  AAPS PharmSciTech       Date:  2003       Impact factor: 3.246

Review 3.  Delivery of hormones: some new concepts.

Authors:  W A Hermens
Journal:  Pharm Weekbl Sci       Date:  1992-08-21

4.  Design of compounds that increase the absorption of polar molecules.

Authors:  C L Bowe; L Mokhtarzadeh; P Venkatesan; S Babu; H R Axelrod; M J Sofia; R Kakarla; T Y Chan; J S Kim; H J Lee; G L Amidon; S Y Choe; S Walker; D Kahne
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

Review 5.  Drug metabolism in the nasal mucosa.

Authors:  M A Sarkar
Journal:  Pharm Res       Date:  1992-01       Impact factor: 4.200

6.  Intranasal and intramuscular human calcitonin in female osteoporosis and in Paget's disease of bones: a pilot study.

Authors:  A E Pontiroli; E Pajetta; A Calderara; M Alberetto; G Pozza; V Manganelli; G Resmini; L Tessari; V Maresca
Journal:  J Endocrinol Invest       Date:  1991-01       Impact factor: 4.256

7.  Nasal absorption in the rat. III. Effect of lysophospholipids on insulin absorption and nasal histology.

Authors:  S G Chandler; N W Thomas; L Illum
Journal:  Pharm Res       Date:  1994-11       Impact factor: 4.200

8.  Bioavailability and hypoglycemic activity of the semisynthetic bile acid salt, sodium 3alpha,7alpha-dihydroxy-12-oxo-5beta-cholanate, in healthy and diabetic rats.

Authors:  M Mikov; N S Boni; H Al-Salami; K Kuhajda; S Kevresan; S Golocorbin-Kon; J P Fawcett
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2007 Jan-Mar       Impact factor: 2.441

9.  Increased protein secretion and adherence to HeLa cells by Shigella spp. following growth in the presence of bile salts.

Authors:  L M Pope; K E Reed; S M Payne
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

10.  In vitro nasal transport across ovine mucosa: effects of ammonium glycyrrhizinate on electrical properties and permeability of growth hormone releasing peptide, mannitol, and lucifer yellow.

Authors:  P M Reardon; C H Gochoco; K L Audus; G Wilson; P L Smith
Journal:  Pharm Res       Date:  1993-04       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.